Dr. Varshasb Broumand, MD

Dr. Broumand practices at Total Vascular Care in San Antonio, Texas.

Dr. Broumand's NPI, 1154329720, was assigned on July 8, 2005. Dr. Broumand graduated from University of Miami, Miller School of Medicine in 1995. Dr. Broumand's Texas license number on file is M8559.

Dr. Broumand's primary practice is Total Vascular Care, at 215 N San Saba, Suite 201, San Antonio, TX 78207. The practice phone is (210) 212-8622.

Dr. Broumand's primary practice is Total Vascular Care in San Antonio, Texas. Dr. Broumand is also affiliated with Methodist Hospital. The medical group on file is South Texas Renal Care Group. Dmand AI also links Dr. Broumand to 1 more hospital, 3 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Broumand practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Broumand's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Broumand is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Broumand's licenses on file in 6 states: Texas, Virginia, Florida, Kentucky, Maryland and Tennessee.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and kidney cysts among the conditions Dr. Broumand treats.

CMS data shows 1,733 Medicare services from Dr. Broumand across 15 procedure codes in 2024, for 472 Medicare patients. Medicare paid $155,725 for them.

CMS counts 472 Medicare patients who saw Dr. Broumand in 2024. The largest group is 75 to 84, with 197 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 14% are also on Medicaid. Their average risk score is 3.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Broumand's median patient age at 70, with 51% women.

In 2024, Dr. Broumand wrote 4,066 Medicare Part D claims for 481 patients. 71% of them were for generic drugs. CMS names the drug for 3,625 of them, across 76 drugs with 11 or more claims each, at $1,541,790 in total drug cost. In 2023, CMS named 2,925 claims across 69 drugs.

Dr. Broumand accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Broumand as offering telehealth.

Dmand AI links 4 papers to Dr. Broumand, published from 2021 to 2024. The most frequent topics are Renal Insufficiency, Chronic, Calcifediol and Hyperparathyroidism, Secondary. Dr. Broumand has published most often in Am J Nephrol. Dr. Broumand's most frequent co-authors are Akhtar Ashfaq, MD, George Z. Fadda, MD and Michael J. Germain, MD.

CMS Open Payments shows 1,259 general payments to Dr. Broumand from 58 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 55% of the total. Outset Medical Inc paid the most, $42,900.

Dmand AI lists 2 awards for Dr. Broumand, most recently ASN Fellow in 2012.

Dr. Broumand graduated from University of Miami, Miller School of Medicine in 1995. Dr. Broumand is a member of ACP and ASN.

Dr. Broumand is in network with 23 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Aetna. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.